CAN
VNDA icon

Cetera Advisor Networks’s Vanda Pharmaceuticals VNDA Stock Holding History

Cetera Advisor Networks’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-250
Closed -$3K – 2965
2020
Q2 		$3K Buy
+250
New +$2.83K ﹤0.01% 3169

Other funds holding VNDA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Prudential Financial
Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return

Cetera Advisor Networks's VNDA Position: Q3 2020 in Review

Cetera Advisor Networks sold out of Vanda Pharmaceuticals (VNDA) in Q3 2020, closing a stake of 250 shares — an estimated $3K sold.

Cetera Advisor Networks first reported a position in VNDA in Q2 2020 and held it in 1 quarter. The position peaked at $3K in Q2 2020. 164 funds tracked by Wall St. Rank hold VNDA as of Q3 2020.

  • Cetera Advisor Networks reported no remaining Vanda Pharmaceuticals position as of Q3 2020 after selling out during the quarter.
  • Cetera Advisor Networks sold 250 Vanda Pharmaceuticals shares in Q3 2020, an estimated $3K.
  • Cetera Advisor Networks first reported a position in Vanda Pharmaceuticals in Q2 2020 and held it in 1 quarter.
  • Cetera Advisor Networks's Vanda Pharmaceuticals position peaked at $3K in Q2 2020.
  • 164 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q3 2020.

Based on Cetera Advisor Networks's 13F filing for Q3 2020, filed 13 Nov 2020.